These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8777670)

  • 21. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
    Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Systemic and pulmonary hemodynamics in the course of substitute therapy with exosurf neonatal in newborn infants with respiratory distress syndrome].
    Milenin OB; Efimov MS
    Anesteziol Reanimatol; 1996; (6):7-10. PubMed ID: 9045592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Criteria for use of colfosceril (Exosurf) in neonates.
    Bhatt-Mehta V; Schumacher RE
    Clin Pharm; 1992 Apr; 11(4):355-7. PubMed ID: 1563234
    [No Abstract]   [Full Text] [Related]  

  • 24. [Exosurf-Neonatal: the synthetic surfactant. Introductory symposium, 20 June 1992].
    Monatsschr Kinderheilkd; 1992 Sep; 140(9 [EXOSURF]):1-12. PubMed ID: 1406736
    [No Abstract]   [Full Text] [Related]  

  • 25. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Respiratory distress syndrome in New Zealand: evidence from the OSIRIS trial of exogenous surfactant (Exosurf).
    Wach R; Darlow B; Bourchier D; Broadbent R; Knight D; Selby R
    N Z Med J; 1994 Jun; 107(980):234-7. PubMed ID: 8208494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings.
    Levine D; Edwards DK; Merritt TA
    AJR Am J Roentgenol; 1991 Aug; 157(2):371-4. PubMed ID: 1853824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
    Zhang L; Cao HY; Zhao S; Yuan LJ; Han D; Jiang H; Wu S; Wu HM
    Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Instillation rate effects of Exosurf on cerebral and cardiovascular haemodynamics in preterm neonates.
    Saliba E; Nashashibi M; Vaillant MC; Nasr C; Laugier J
    Arch Dis Child Fetal Neonatal Ed; 1994 Nov; 71(3):F174-8. PubMed ID: 7820712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
    Dechant KL; Faulds D
    Drugs; 1991 Nov; 42(5):877-94. PubMed ID: 1723378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.
    Stenson BJ; Glover RM; Parry GJ; Wilkie RA; Laing IA; Tarnow-Mordi WO
    Arch Dis Child Fetal Neonatal Ed; 1994 Jan; 70(1):F19-24. PubMed ID: 8117122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of the acute response to surfactant therapy by pulmonary function testing.
    Wallenbrock MA; Sekar KC; Toubas PL
    Pediatr Pulmonol; 1992 May; 13(1):11-5. PubMed ID: 1589306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.
    Sehgal SS; Ewing CK; Richards T; Taeusch HW
    J Natl Med Assoc; 1994 Jan; 86(1):46-52. PubMed ID: 8151722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exogenous surfactant decreases oxygenation in Escherichia coli endotoxin-treated neonatal piglets.
    Sood SL; Balaraman V; Finn KC; Wilkerson SY; Mundie TG; Easa D
    Pediatr Pulmonol; 1996 Dec; 22(6):376-86. PubMed ID: 9016471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Natural and synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Bratlid D; Farstad T
    Tidsskr Nor Laegeforen; 1994 Jan; 114(1):33-6. PubMed ID: 8296279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surfactant replacement therapy: issues related to currently available preparations.
    Bose G
    Neonatal Netw; 1992 Jun; 11(4):vii-xii. PubMed ID: 1608367
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of Exosurf Neonatal, a synthetic surfactant, in the treatment of respiratory distress syndrome in the newborn].
    Mikhel'sonVA ; Grebennikov VA; Belaĭ VA; Everstova TN
    Anesteziol Reanimatol; 1995; (1):4-7. PubMed ID: 7605034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Turnover of exogenous artificial surfactant.
    Ashton MR; Postle AD; Hall MA; Austin NC; Smith DE; Normand IC
    Arch Dis Child; 1992 Apr; 67(4 Spec No):383-7. PubMed ID: 1586175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OSIRIS trial.
    Morley C
    Lancet; 1993 Jan; 341(8838):172-3; author reply 173-4. PubMed ID: 8093764
    [No Abstract]   [Full Text] [Related]  

  • 40. Surfactant for babies.
    Lancet; 1992 Dec; 340(8832):1387. PubMed ID: 1360097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.